TAG:
lab test
Forecast: Tough Fee Cuts Are in Labs’ Future
By R. Lewis Dark | From the Volume XVIII No. 14 – October 17, 2011 Issue
EVERY CLINICAL LABORATORY AND ANATOMIC PATHOLOGY GROUP PRACTICE in the United States should prepare for some big-time financial belt-tightening during the next 36 months. That certainly is the message coming from intense budget battles unfolding in Washington, DC, this fall. Most of you reading this…
Congress Likely to Pass Deep Cuts in Lab Test Fees
By Robert Michel | From the Volume XVIII No. 14 – October 17, 2011 Issue
CEO SUMMARY: All signs point to a potentially dismal financial outcome for the clinical lab testing industry as Congress tries to trim spending by $1.2 trillion over the next 10 years. At least three proposals to significantly cut lab test reimbursement are in active debate by fe…
In Massachusetts, AG Targets Drug Testing Labs
By Robert Michel | From the Volume XVIII No. 14 – October 17, 2011 Issue
CEO SUMMARY: Since taking office in 2007, Massachusetts Attorney General Martha Coakley has aggressively pursued civil charges against drug testing labs. Last month, Coakley announced a criminal arrest in one ongoing investigation after a grand jury indicted a physician in a kick…
Hospital Lab Uses HIE To Win Outreach Clients
By Robert Michel | From the Volume XVIII No. 14 – October 17, 2011 Issue
CEO SUMMARY: Health information exchanges (HIEs) are operating nationwide, but few handle lab test orders and results with ease the way HealthBridge does. This long-established HIE in Cincinnati, Ohio, allows physicians to send lab test orders from their electronic health record …
Why Pathologists Benefit from Growth of In-Office Path Labs
By Robert Michel | From the Volume XVIII No. 14 – October 17, 2011 Issue
Dear Editor: Your article on the trend of office-based physicians building in-clinic anatomic pathology laboratories was fascinating, but in my opinion, it was off the mark. In the article, “AP Labs in Doc’s Clinics Now an Established Fact” (See TDR, September 6, 20…
Rosetta Genetics, Aureon Biosciences, Plus Diagnostics, Atherotech, Sequenom
By Robert Michel | From the Volume XVIII No. 14 – October 17, 2011 Issue
ROSETTA GENOMICS TO LAY OFF 35 EMPLOYEES TO CUT EXPENSES AND SHIFT MORE FUNDING toward sales of its proprietary molecular tests, Rosetta Genomics says it will eliminate 35 jobs. The company, based in Israel, operates a clinical laboratory in Philadelphia, Pe…
Does Anyone Know the Law in California?
By R. Lewis Dark | From the Volume XVIII No. 13 – September 26, 2011 Issue
WHAT IS THE LAW IN CALIFORNIA THAT DEFINES PROVIDER PRICING and how Medi-Cal should be billed? You probably think that question would be rather easy to answer after you read one of the state statutes that governs pricing relative to Medi-Cal claims. Popularly known among the lab industry as 51501(a),…
LabCorp Inks Agreement In Medi-Cal Pricing Case
By Robert Michel | From the Volume XVIII No. 13 – September 26, 2011 Issue
CEO SUMMARY: In its “Settlement Agreement and Release” with the California Attorney General (AG), Laboratory Corporation of America has negotiated terms that essentially match the agreement that exists between Quest Diagnostics Incorporated and the California AG. These settle…
National Group Names Riedel “Whistleblower of the Year”
By Robert Michel | From the Volume XVIII No. 13 – September 26, 2011 Issue
WHISTLEBLOWING HAS ITS REWARDS. During 2011, one laboratory whistleblower not only harvested tens of millions of dollars in settlement awards, but he was recently honored by a national group for these same efforts. Chris Riedel, President of Hunter Laboratories, Inc., in Campbell, C…
POC Testing Plays Role In Penna. Patient’s Death
By Robert Michel | From the Volume XVIII No. 13 – September 26, 2011 Issue
CEO SUMMARY: In the report by the Pennsylvania Department of Health on the death of a patient at Lehigh Valley Hospital, it was noted that the clinical staff failed to notice discrepancies between results from point-of-care (POC) tests at the bedside and lab test results from blo…
CURRENT ISSUE

Volume XXXII, No. 13 – September 15, 2025
The Dark Report examines a new bill that would reform PAMA and avoid reimbursement rate cuts scheduled for January 2026. Clinical laboratory leaders are urged to make their voices heard in Congress. Also, an expert describes how labs can fix pre-analytical errors and avoid disaster.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized